K. Krenn

发表

Understanding Cellular Redox Homeostasis: A Challenge for Precision Medicine

K. U. Klein, V. Tretter, Beatrix Hochreiter, 2021, International journal of molecular sciences.

Apollon/RNF41 Myocardial Messenger RNA Diagnoses Cardiac Allograft Apoptosis in Rejection

A. Zuckermann, Anita C. Thomas, M. Gmeiner, 2010, Transplantation.

Serum Matrix Metalloprotease‐1 and Vascular Endothelial Growth Factor–A Predict Cardiac Allograft Rejection

A. Aliabadi, A. Zuckermann, M. Gmeiner, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study

A. Böhm, H. Greinix, P. Kalhs, 2012, Leukemia.

Persistent plasminogen activator inhibitor 1 gene expression in cardiac transplant recipients with idiopathic dilated cardiomyopathy.

M. Gmeiner, K. Krenn, S. Aharinejad, 2010, The Journal of thoracic and cardiovascular surgery.

Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.

W. Klepetko, K. Krenn, S. Aharinejad, 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

CD 19 1 CD 21 low B cells and patients at risk for NIH-de fi ned chronic graft-versus-host disease with bronchiolitis obliterans syndrome

G. Dekan, W. Pickl, H. Greinix, 2013 .

CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.

G. Dekan, W. Pickl, H. Greinix, 2013, Blood.

TRANSPLANTATION CD19 1 CD21 low B cells and patients at risk for NIH-de ﬁ ned chronic graft-versus-host disease with bronchiolitis obliterans syndrome

G. Dekan, W. Pickl, H. Greinix, 2013 .

donor lung grafts endothelial growth factor-A promoter mediates increased vascular permeability in Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular

W. Klepetko, G. Seebacher, K. Krenn, 2013 .

Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts.

W. Klepetko, G. Seebacher, K. Krenn, 2004, The Annals of thoracic surgery.

Oxygen conditions oscillating between hypoxia and hyperoxia induce different effects in the pulmonary endothelium compared to constant oxygen conditions

Akos Tiboldi, K. Markstaller, R. Ullrich, 2021, Physiological reports.

Donor Myocardial HIF‐1α Is an Independent Predictor of Cardiac Allograft Dysfunction: A 7‐Year Prospective, Exploratory Study

A. Zuckermann, E. Wolner, K. Krenn, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Recipient Vascular Endothelial Growth Factor Serum Levels Predict Primary Lung Graft Dysfunction

G. Lang, W. Klepetko, K. Krenn, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Broncho‐alveolar Lavage Matrix Metalloproteases as a Sensitive Measure of Bronchiolitis Obliterans

P. Jaksch, W. Klepetko, K. Krenn, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.

G. Dekan, M. Gmeiner, K. Krenn, 2015, The Journal of thoracic and cardiovascular surgery.

Tidal Volume–Dependent Activation of the Renin-Angiotensin System in Experimental Ventilator-Induced Lung Injury*

Xinjun Mao, R. Ullrich, B. Podesser, 2022, Critical care medicine.

Practice of oxygen use in anesthesiology – a survey of the European Society of Anaesthesiology and Intensive Care

S. D. De Hert, J. Hendrickx, K. Krenn, 2022, BMC Anesthesiology.

The systemic renin-angiotensin system in COVID-19

A. Heinzel, E. Puchhammer-Stöckl, A. Zoufaly, 2022, Scientific Reports.

Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial

R. Lucas, R. Hermann, K. Markstaller, 2017, Critical Care.

Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS—a randomized, placebo-controlled, double-blind trial

P. Meybohm, P. Kranke, B. Zwissler, 2021, Trials.

Donor Serum SMARCAL1 Concentrations Predict Primary Graft Dysfunction in Cardiac Transplantation

Seyedhossein Aharinejad, A. Aliabadi, A. Zuckermann, 2009, Circulation.

Differential Role of TGF‐β1/bFGF and ET‐1 in Graft Fibrosis in Heart Failure Patients

A. Zuckermann, K. Krenn, S. Aharinejad, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome

R. Ullrich, V. Tretter, K. Krenn, 2022, Frontiers in Physiology.

Usefulness and limitations of the acute respiratory distress syndrome definitions in non-intubated patients. A narrative review

R. Ullrich, Sebastian König, K. Krenn, 2023, Frontiers in Medicine.

Combined angiotensin-converting enzyme and aminopeptidase inhibition for treatment of experimental ventilator-induced lung injury in mice

Xinjun Mao, R. Ullrich, V. Tretter, 2023, Frontiers in Physiology.

P. Meybohm, P. Kranke, B. Zwissler, 2021, Trials.

Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study.

P. Jaksch, W. Klepetko, K. Markstaller, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Oral inhalation of AP301 peptide activates pulmonary oedema clearance: Initial results from a phase IIa clinical trial in mechanically ventilated ICU patients

R. Lucas, R. Hermann, K. Markstaller, 2014 .

Apollon/RNF41 Myocardial Messenger RNA Diagnoses Cardiac Allograft Apoptosis in Rejection

A. Zuckermann, Anita C. Thomas, M. Gmeiner, 2010, Transplantation.

Matrix metalloproteases and their tissue inhibitor in cardiac transplantation.

A. Zuckermann, E. Wolner, G. Seebacher, 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.